Date Filed | Type | Description |
09/27/2023 |
8-K
| Quarterly results |
08/16/2023 |
144
| Form 144 - Report of proposed sale of securities: |
08/04/2023 |
10-Q
| Quarterly Report for the period ended June 30, 2023 |
08/01/2023 |
8-K
| Quarterly results |
07/25/2023 |
8-K
| Quarterly results |
05/31/2023 |
8-K
| Regulation FD Disclosure, Financial Statements and Exhibits Interactive Data |
05/19/2023 |
8-K
| Regulation FD Disclosure Interactive Data |
05/08/2023 |
8-K
| Submission of Matters to a Vote of Security Holders Interactive Data |
05/03/2023 |
10-Q
| Quarterly Report for the period ended March 31, 2023 |
04/27/2023 |
8-K
| Quarterly results |
04/03/2023 |
ARS
| Form ARS - Annual Report to Security Holders: |
04/03/2023 |
DEF 14A
| Form DEF 14A - Other definitive proxy statements: |
03/14/2023 |
8-K
| Regulation FD Disclosure Interactive Data |
02/27/2023 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
02/27/2023 |
10-K
| Annual Report for the period ended December 31, 2022 |
02/09/2023 |
SC 13G/A
| VANGUARD GROUP INC reports a 9.8% stake in Encompass Health Corp. |
02/07/2023 |
8-K
| Investor presentation, Quarterly results |
02/06/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
01/30/2023 |
SC 13G/A
| BlackRock Inc. reports a 11.3% stake in ENCOMPASS HEALTH CORPORATION |
01/30/2023 |
SC 13G/A
| BlackRock Inc. reports a 11.3% stake in ENCOMPASS HEALTH CORPORATION |
01/13/2023 |
5
| Jacobsmeyer Barbara Ann (President & CEO, HHH) has filed a Form 5 on Encompass Health Corp |
12/13/2022 |
8-K
| Quarterly results |
11/14/2022 |
8-K
| Quarterly results |
11/02/2022 |
10-Q
| Quarterly Report for the period ended September 30, 2022 |
10/26/2022 |
8-K
| Quarterly results |
10/13/2022 |
8-K
| Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S... |
08/04/2022 |
10-Q
| Quarterly Report for the period ended June 30, 2022 |
08/01/2022 |
8-K
| Investor presentation, Quarterly results |
07/07/2022 |
8-K
| Quarterly results |
06/21/2022 |
8-K
| Quarterly results |
06/13/2022 |
8-K
| Quarterly results |
06/07/2022 |
8-K
| Quarterly results |
06/07/2022 |
8-K
| Quarterly results |
05/09/2022 |
8-K
| Quarterly results |
|